The Evidence Behind The Experience

NeuronsVR exclusive peer-reviewed research and registered clinical trials for therapy through VR.

—— NeuronsVR Clinical Framework

Behavioural & Psychological Symptoms of Dementia:

NeuronsVR's framework outlines the spectrum of behavioral and psychological symptoms of dementia, ranging from baseline wellbeing at Tier 1 through to Tier 7 extreme care.

Each tier represents a distinct level of support, giving care teams a structured model to identify client needs and deliver appropriate non-pharmacological care.

—— Dementia Facts · Australia (2024)

The Numbers Behind The Need

DEMENTIA IN AUSTRALIA · 2024

425,000

Australians living with dementia

2023: 411,100

2065 (projected): ~1,100,000

AGED CARE RESIDENTS

54%

of residential aged care living with dementia

UNPAID CARER BURDEN

60+ hrs

Average weekly care by unpaid carers of people with dementia

Each tile = 1 hour per week · 60 hrs total

—— Aged Care Quality Standards

Meeting Aged Care Quality Standards With NeuronsVR Therapy

—— Published Research

Peer Reviewed and Published.

FACILITY TRIAL

NeuronsVR Trial Virtual Reality Dementia Specific

Consistent observed improvements in mood, social engagement, and cognitive activity, with previously isolated residents participating in group sessions and family members reporting residents recalled VR experiences despite daily memory lapses.

CLINICAL TRIAL

NeuronsVR Virtual Reality Therapy for People with Dementia in Acute Hospital Settings

A registered pilot RCT measuring the effect of NeuronsVR therapy on the dose and frequency of chemical restraint required for people experiencing BPSD in acute hospital settings; results pending publication.

CLINICAL TRIAL

A Pilot RCT of NeuronsVR therapy for BPSD in dementia

Registered as a pilot RCT to evaluate VR therapy as a non-pharmacological approach to managing agitation, anxiety, and behavioural distress in people with dementia admitted to acute hospital settings.

PEER-REVIEWED

NeuronsVR: Virtual reality therapy for people living with dementia during an acute hospital admission

In a sample of hospitalised people with dementia, 100% of participants completed the VR intervention and achieved a mean Engagement of a Person with Dementia Scale (EPWDS) score of 40.0/50.0 (SD 7.3), with the majority reporting they 'liked' or 'strongly liked' the experience, demonstrating feasibility, acceptability and safety in an acute hospital setting.

NEWS STORY

NeuronsVR Therapy programs individual care plans with evidence-based, non-pharmacological interventions.

Across multiple Calvary aged care homes, residents experienced improved emotional wellbeing, reminiscence, and cultural connection through NeuronsVR sessions, including a multilingual pilot at Calvary Springvale and a 95-year-old resident moved to tears at a virtual classical music concert at Calvary Flora McDonald.

PEER-REVIEWED

A Systematic Review of IS Literature in Dementia Care: An Application of the NASSS Framework

A PRISMA-methodology systematic review identified five key themes to guide future dementia care technology research, confirming VR as a clinically relevant intervention and highlighting interoperability, economic viability, and alignment with patient and caregiver needs as the primary implementation challenges.

—— Research Partners

Research Conducted With Australia's Leading Institutions.

Australian facilities and research institutions have trialled NeuronsVR in real care settings. Results have been registered with ANZCTR and published across indexed academic journals.